World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 16 December 2017
Main ID:  NCT02183519
Date of registration: 02/07/2014
Prospective Registration: Yes
Primary sponsor: University of Florida
Public title: Respiratory Kinematics of Cough in Healthy Older Adults and Parkinson's Disease
Scientific title: Respiratory Kinematics of Reflex and Voluntary Cough in Healthy Older Adults and Parkinson's Disease
Date of first enrolment: October 2014
Target sample size: 44
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02183519
Study type:  Interventional
Study design:  Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).  
Phase:  Phase 1/Phase 2
Countries of recruitment
United States
Contacts
Name:     Alexandra E. Brandimore, M.A. CCC/SLP
Address: 
Telephone:
Email:
Affiliation:  University of Florida
Name:     Karen W. Hegland, Ph.D.
Address: 
Telephone:
Email:
Affiliation:  University of Florida
Key inclusion & exclusion criteria

Inclusion Criteria:

- Age 55-85 years

- Ability to provide informed consent

For participants with Parkinson's disease (PD):

- Diagnosis of PD (Hoehn & Yahr stages II-IV) by a University of Florida Movement Disorders
fellowship trained neurologist having completed a clinical assessment of each participant's
PD severity and arriving at the diagnosis of PD by applying strict United Kingdom brain
bank criteria.

Exclusion Criteria:

Participants with PD:

- History of neurological disorders other than PD (e.g. multiple sclerosis, stroke, brain
tumor, etc)

Healthy older adults:

- History of neurological disease including PD

- History of head and neck cancer

- History of breathing disorders or disease (i.e. chronic obstructive pulmonary disease,
asthma)

- History of smoking for more than 5 years at any one time (as this reduces the
sensitivity to capsaicin)

- History of chest infection the last 5 weeks

- Failure of a screening test of pulmonary function (e.g. forced expiratory volume in
one second/forced vital capacity<75%)

- Difficulty complying due to neuropsychological dysfunction (i.e. severe depression)



Age minimum: 55 Years
Age maximum: 85 Years
Gender: All
Health Condition(s) or Problem(s) studied
Cough
Parkinson's Disease
Intervention(s)
Other: Voluntary cough test
Drug: Capsaicin
Primary Outcome(s)
Peak Expiratory Flow Rate [Time Frame: 1-2 hours]
Secondary Outcome(s)
Secondary ID(s)
IRB201400477
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available: Yes
Date Posted: 24/03/2017
Date Completed:
URL: https://clinicaltrials.gov/ct2/show/results/NCT02183519
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history